Evidence map›Paper›PMID 38227660›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Justine E Roderick-Richardson, Sung-Eun Lim, Sakiko Suzuki, Mohd Hafiz Ahmad, Jonathan Selway, Reem Suleiman, Keshab Karna, Jesse Lehman, Joanne O'Donnell, Lucio H Castilla and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Justine E Roderick-Richardson *Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605.
Sung-Eun Lim *Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605.
Sakiko SuzukiDepartment of Medicine, Division of Hematology-Oncology, University of Massachusetts Chan Medical School, Worcester, MA 01605.
Mohd Hafiz AhmadDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605.
Jonathan SelwayDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605.ORCID 0000-0002-3175-1953
Reem SuleimanDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605.
Keshab KarnaDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605.ORCID 0000-0003-1389-8975
Jesse LehmanDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605.ORCID 0000-0002-3729-2866
Joanne O'DonnellSchool of Biological Sciences, Monash University, Clayton, VIC 3800, Australia.
Lucio H CastillaDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605.ORCID 0000-0002-7450-758X
Jonathan MaelfaitVlaams Instituut voor Biotechnologie-UGent Center for Inflammation Research, Ghent 9052, Belgium.ORCID 0000-0002-1476-0583
Jan RehwinkelMedical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.ORCID 0000-0003-3841-835X
Michelle A KelliherDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605.ORCID 0000-0001-9211-3659
University of Massachusetts Chan Medical School · USMonash University · AUUniversity of Oxford · GBVlaams Instituut voor Biotechnologie · BE

Funding

Mechanism(s) of TAL-1/SCL-mediated LeukemogenesisR01CA096899 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MICHELLE ALICE KELLIHER · 2004 to 2026
$6.9M
Rip Proteins in Innate Immune SignalingR01AI075118 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KELLIHER, MICHELLE ALICE · 2009 to 2024
$6.7M
Rip Proteins in Innate Immune SignalingR56AI075118 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KELLIHER, MICHELLE ALICE · 2007 to 2007
$406k
Medical Research Council MC_UU_00008/8NCI NIH HHS R01 CA096899NIAID NIH HHS R01 AI075118NIAID NIH HHS R56 AI075118
6 · The paper itself

Abstract

Human bone marrow failure (BMF) syndromes result from the loss of hematopoietic stem and progenitor cells (HSPC), and this loss has been attributed to cell death; however, the cell death triggers, and mechanisms remain unknown. During BMF, tumor necrosis factor-α (TNFα) and interferon-γ (IFNγ) increase. These ligands are known to induce necroptosis, an inflammatory form of cell death mediated by RIPK1, RIPK3, and MLKL. We previously discovered that mice with a hematopoietic RIPK1 deficiency (

Indexed as

Nucleic AcidsPancytopeniaAnimalsApoptosisBone Marrow Failure DisordersCell DeathHematopoietic Stem CellsHumansMiceNecrosisReceptor-Interacting Protein Serine-Threonine KinasesRNA-Binding ProteinsNucleic AcidsReceptor-Interacting Protein Serine-Threonine KinasesRNA-Binding ProteinsZbp1 protein, mouseapoptosisbone marrow failurehematopoiesisnecroptosisZBP1

Identifiers

PMID38227660
PMCPMC10823230
OpenAlexW4390904738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.